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Background: Icterus is the most common medical problem in neonates and photo-
therapy is the standard treatment for neonatal hyperbilirubinemia. This study 
aimed to compare the efficacy and length of hospital stay of double and triple pho-
totherapy in newborns with indirect hyperbilirubinemia.
Methods: In a clinical trial, 40 healthy term newborns (gestational age > 37 weeks) 
with bilirubin ≥ 12 and ≥ 15 mg/dL in the second and third day, respectively, were 
randomly assigned to triple (n = 20) or double phototherapy (n = 20) groups. Total 
and direct serum bilirubin were measured at admission, 8, 16, and 24 hours after 
beginning of phototherapy, and every 12 hours thereafter until discharge (when 
bilirubin levels reached ≤ 10 mg/dL).
Results: There were 21 male (52%) and 19 female (48%) term neonates, with 
significant difference between patients’ age, weight, and age of icterus. There was 
no significant difference in the rate of bilirubin decline between the two groups 
within the first 8, 16 and 24 hours. There was no significant difference in mean 
length of hospital stay between the two groups. Analysis of complications showed 
no difference between triple and double groups.
Conclusion: Triple phototherapy failed to reduce total serum bilirubin and shorten 
length of hospitalization more rapidly than double phototherapy.
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Icterus is the most common medical problem in 
neonates.1−3 Around 50−70% of term and 80% of pre-
term neonates suffer from icterus.1−5 Icterus is also 
the most common cause of neonate readmission.1,5,6 
Although it is usually benign in term and preterm 
neonates,1,3,7,8 severe hyperbilirubinemia is a medi-
cal emergency9 because bilirubin is a neurotoxic 
material3,10 which can lead to neurologic defects 
even in healthy term neonates.4,7,11 Therefore, 
management of hyperbilirubinemia in newborns is 
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still a critical issue. For the past four decades, pho-
totherapy has remained a standard treatment for 
neonatal hyperbilirubinemia.4−6,12
The effect of phototherapy depends on the in-
tensity of radiation (which in turn depends on the 
characteristics of radiation, number of radiation 
sources, and exposed body area) and the distance 
between the body and the source of radiation.2,4−7 
Because of this, several studies have compared the 
efficacy of single and double phototherapy,10,13 
but there is no data comparing double and triple 
phototherapy.
Intensive phototherapy is a method used for the 
management of neonatal hyperbilirubinemia. The 
intensive phototherapy devices used included 11 
phototherapy lamps, six of which were put above 
the bassinet, and five below the bassinet. Because 
devices for intensive phototherapy are rare or un-
available in Iran, some centers use triple photo-
therapy (adding another phototherapy device to 
double phototherapy) for intensive phototherapy.
The purpose of this study was to compare the 
benefits, complications, and length of hospitalization 
for double and triple phototherapy treatment in 
newborns with indirect hyperbilirubinemia.
2. Methods and Materials
2.1. Study population
This study was a clinical trial conducted in a neona-
tal ward of Bandar Abbas Pediatric Hospital (Bandar 
Abbas University of Medical Science), in Bandar 
Abbas, Iran, between January and May 2006. All sub-
jects who met the following inclusion criteria en-
tered to the study: healthy term newborn > 37 weeks, 
neonatal age > 24 hours, weight > 2500 grams, indi-
rect hyperbilirubinemia, breast-fed, bilirubin lev-
els ≥ 12 and ≥ 15 mg/dL on the 2nd and 3rd day, 
respectively. Neonates were defined as newborns 
with a gestational age > 37 weeks with no medical 
problems and/or hemolysis. Exclusion criteria in-
cluded infectious, metabolic, or hemolytic diseases 
(including porphyria, glucose 6-phosphate dehydro-
genase deficiency, and ABO alloimmunization), pos-
itive Coombs’ test, high reticulocyte count, abnormal 
peripheral blood smear, occurrence of icterus within 
the first 24 hours, increased levels of direct serum 
bilirubin or maternal history of phenobarbital con-
sumption before, during, or after child birth. Also 
excluded were neonates who were candidates for 
blood exchange. Using simple randomization (single 
sequence of random assignment), 40 patients were 
randomly assigned to triple (n = 20) and double 
(n = 20) phototherapy groups. Triple and double 
groups underwent phototherapy using triple and 
double radiation sources, respectively. All neonates 
were in bassinets during phototherapy. In double 
phototherapy (conventional method), two single 
phototherapy devices were used: one was placed 
above the bassinet, and the other was placed in line 
with its length, both with a 25 cm distance from it. 
In triple phototherapy, in addition to the two pre-
vious devices, a third one was placed in the line 
with width of the bassinette, and with a 35 cm dis-
tance from the bed. All phototherapy devices were 
made by Iran Behkar Medical Industry Co. (Tehran, 
Iran); fluorescent lamps were made by Royal Philips 
Electronics, Inc. (Amsterdam, the Netherlands) with 
20 W power. The fluorescent lamps were exchanged 
and used for 500 hours. In each subject, total and 
direct serum bilirubin were measured at admission, 
8, 16, and 24 hours after the beginning of photo-
therapy and then every 12 hours until discharge 
from hospital. Bilirubin was measured by the con-
ventional indirect diazo method. Phototherapy was 
stopped and the newborns was discharged when 
bilirubin levels decreased to ≤10 mg/dL. A pedia-
trician visited all subjects once a day to monitor 
for phototherapy side effects. Recorded data in-
cluding gender, age and weight, age of occurrence 
of icterus, bilirubin levels in scheduled time, dura-
tion, and phototherapy complications.
The study protocol was approved by Institutional 
Review Board at Bandar Abbas University of Medical 
Science. Informed consent was obtained from all 
parents before enrollment in the study.
2.2. Statistical analysis
Statistical analysis was conducted using SPSS 
version 11.5 (SPSS Inc., Chicago, IL, USA). Analysis 
of variance and independent Student’s t tests (with 
95% confidence intervals) were used to compare 
quantitative data. Statistical significance was de-
fined as p < 0.05.
3. Results
There were 21 male (52%) and 19 female (48%) term 
neonates (a non-significant difference). Patients’ 
characteristics are shown in Table 1. Insignificant 
difference between patients’ age, weight, and age 
of icterus implied that our randomization was suit-
able and accurate.
Comparison of total serum bilirubin in triple and 
double groups showed no significant differences at 
the times measured (Table 1). There was no signifi-
cant difference in the rate of bilirubin decline be-
tween the two groups within the first 8, 16, and 24 
hours. Thus, both triple and double phototherapy re-
duced total serum bilirubin in a comparable manner.
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We compared length of hospitalization between 
triple and double groups and found that the mini-
mal and maximal lengths of hospitalization were 
16 and 60 hours, respectively, in both groups. Length 
of hospital stay was not significantly different be-
tween the two groups (Table 1). There was no sig-
nificant difference in the rate of bilirubin reduction 
between the two groups (p > 0.05).
Analysis of complications showed no difference 
between triple and double groups. In term of com-
plication, loose feces were seen in two newborns 
in the triple phototherapy group and one newborn 
in the double phototherapy group. Maculopapular 
rash was observed in one neonate in the double 
phototherapy group.
4. Discussion
We compared the benefits, complications and 
length of hospitalization between double and triple 
phototherapy in term newborns with indirect hy-
perbilirubinemia. To the authors’ knowledge, this is 
the first time such a comparison has been made. 
There was no significant difference in the speed of 
bilirubin decline and length of hospital stay be-
tween the two groups. Kang and Shankaran’s study 
indicated that double phototherapy more rapidly 
reduced serum bilirubin concentration, compared 
with single phototherapy.14 Thus, length of hospi-
talization of double phototherapy was significantly 
shorter than that of the single phototherapy. 
Moreover, the mean of length of hospitalization for 
double phototherapy (14 ± 6 hours) was markedly 
shorter than the result in our study. Sarici et al sug-
gested that length of hospitalization was signifi-
cantly shorter in double phototherapy than single 
phototherapy.13 Meanwhile, the mean of length of 
hospitalization for double phototherapy (31.2 ± 8.5 
hours) was similar to that of our study. A study by 
Nuntnarumit and Naka confirmed the same result,10 
and its mean length of hospitalization for double 
phototherapy (34.9 ± 12.6 hours) was similar to that 
of our study. Several studies have proved the ben-
efits of double phototherapy in comparison with 
single phototherapy.5,9,15
In all the above-mentioned studies, double pho-
totherapy was more effective than single photo-
therapy. This may be related to increased radiation 
and contact surface.
The present study compared the efficacy of dou-
ble and triple phototherapy methods in order to use 
examine the use of triple phototherapy as an al-
ternative intensive phototherapy. As there were no 
similar studies in this field, we cannot directly com-
pare our results with others.
The effect of phototherapy is dependent to radi-
ation rate (lamp number), distance from the photo 
source, contact surface, and photo wavelength. 
The results of our study (no difference between 
the two methods) may be explained by the amount 
of body surface exposed to the photo source (which 
was the same in two studied methods), and the 
distance of the device from the body—the distance 
of the third device was inevitably more than opti-
mal (35 cm), due to space limitations.
4.1. Recommendation
Our results suggest that triple phototherapy has no 
particular benefits compared with double photo-
therapy, but increases the cost of treatment, ex-
penditure of energy, and, probably, dehydration in 
newborns. Triple phototherapy is widely used in Iran 
instead of intensive phototherapy, but the results 
of the present study do not support such a substi-
tution. We recommend carrying out more detailed 
studies regarding the benefits and complications 
of triple phototherapy to help progress towards a 
more effective instrumental design.
Table 1 Characteristics of neonates in double and triple phototherapy groups
Variable
 Double phototherapy  Triple phototherapy 
p  group (n = 20)*  group (n = 20)*
Age (d) 6.4 ± 2.4 6.5 ± 2.2 0.905
Weight (g) 2916 ± 392 2864 ± 400 0.681
Age of icterus (d) 3.4 ± 1.1 3.5 ± 1.1 0.792
Total bilirubin at admission (mg/dL) 16.4 ± 1.3 17 ± 1.3 0.170
Total bilirubin 8 hr after PT (mg/dL) 13.7 ± 1.8 14 ± 1.7 0.590
Total bilirubin 16 hr after PT (mg/dL) 12.2 ± 1.7 12.4 ± 1.7 0.760
Total bilirubin 24 hr after PT (mg/dL) 10.3 ± 2 10.9 ± 1 0.370
Mean length of hospital stay (hr) 34.6 ± 16.5 41.5 ± 17.7 0.211
*Data are presented as mean ± standard deviation. PT = Phototherapy.
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5. Conclusion
Triple phototherapy failed to reduce total serum 
bilirubin or shorten the length of hospitalization 
more rapidly than double phototherapy. Thus, it 
should not be used as a substitution for intensive 
phototherapy in the treatment of newborn icterus.
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